Search results for "Scoring System"

showing 10 items of 69 documents

Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study.

2013

The revised IPSS (IPSS-R) was developed aiming at a better prognostication, taking into account patients treated with best supportive care. We herein validated this model on the basis of data from 1314 patients who received BSC only as well as patients who underwent induction chemotherapy (n=214) or allogeneic transplantation (n=167). We could demonstrate a clear distinction of the IPSS-R risk categories with regard to survival and risk of AML evolution in all patient cohorts. When comparing IPSS-R, IPSS, WHO prognostic scoring system (WPSS) and Duesseldorf score, the best results regarding the ability to predict survival were obtained by the IPSS-R.

OncologyAdultMalemedicine.medical_specialtyPediatricsCancer ResearchScoring systemAllogeneic transplantationSurvivalAdolescenturologic and male genital diseasesRisk AssessmentIPSS; IPSS-R; MDS; Prognosis; Survival; WPSS; Hematology; Oncology; Cancer ResearchRisk categoryYoung AdultRisk FactorsInternal medicinemedicineMDSHumansIn patientAgedAged 80 and overIPSS-Rbusiness.industryIPSSInduction chemotherapyReproducibility of ResultsHematologyMiddle AgedPrognosisSurvival AnalysisMulticenter studyOncologyInternational Prognostic Scoring SystemLeukemia MyeloidMyelodysplastic SyndromesAcute DiseaseMultivariate AnalysisDisease ProgressionWPSSFemalebusinessLeukemia research
researchProduct

Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytoge…

2013

Cytogenetic aberrations identified by metaphase cytogenetics (MC) have diagnostic, prognostic, and therapeutic implications in myelodysplastic syndromes (MDS). However, in some MDS patients MC study is unsuccesful. Single nucleotide polymorphism array (SNP-A) based karyotyping could be helpful in these cases. We performed SNP-A in 62 samples from bone marrow or peripheral blood of primary MDS with an unsuccessful MC study. SNP-A analysis enabled the detection of aberrations in 31 (50%) patients. We used the copy number alteration information to apply the International Prognostic Scoring System (IPSS) and we observed differences in survival between the low/intermediate-1 and intermediate-2/h…

OncologyCancer Researchmedicine.medical_specialtyMyelodysplastic syndromesSingle Nucleotide Polymorphism ArrayCytogeneticsKaryotypeBiologymedicine.diseaseGene dosagemedicine.anatomical_structurePolymorphism (computer science)International Prognostic Scoring SystemInternal medicineGeneticsmedicineBone marrowGenes, Chromosomes and Cancer
researchProduct

Myelodysplastic Syndromes with 20q Deletion: Incidence, Prognostic Value and Impact on Response to Azacitidine of ASXL1 Chromosomal Deletion and Gene…

2020

Introduction : The 20q deletion [del(20q)] is a recurrent chromosomal aberration in myelodysplastic syndromes (MDS) and, as a single abnormality, is associated according to the Revised International Prognostic Scoring System (IPSS-R) with a favorable outcome. However, the breakpoint of del(20q) is very heterogeneous and may cause deletion of the ASXL1 gene (20q11.21). This gene is an important epigenetic regulator of hematopoiesis and its mutations have been associated in MDS with a shorter overall survival (OS) and a lower response to azacitidine (AZA). Aim: To assess the incidence, prognostic value and impact on response to AZA of ASXL1 chromosomal alterations and genetic mutations in MDS…

OncologySanger sequencingmedicine.medical_specialtybusiness.industryMyelodysplastic syndromesImmunologyAzacitidineBreakpointCell BiologyHematologymedicine.diseaseBiochemistryIDH2symbols.namesakeGermline mutationInternational Prognostic Scoring SystemInternal medicinesymbolsMedicinebusinessChromosomal Deletionmedicine.drugBlood
researchProduct

Long-Term Survival Data in 652 Patients with Primary Myelofibrosis or Polycythemia Vera— Trends in Recent Years.

2009

Abstract Abstract 2910 Poster Board II-886 Background: Polycythemia vera (PV) and primary myelofibrosis (PMF) are stem cell-derived myeloproliferative neoplasms characterized clinically by increased red cell volume and bone marrow fibrosis, respectively. Phlebotomy is the cornerstone of treatment in PV whereas hydroxyurea has been the traditional drug of choice in both PV and PMF. Over the last 20 years, several new treatment approaches have been introduced and promoted (e.g. interferon-alpha, anagrelide, thalidomide, allogeneic stem cell transplantation) but their benefit in terms of survival has not been confirmed in controlled studies. Methods: Study patients were recruited form the Mayo…

Oncologymedicine.medical_specialtyPediatricsbusiness.industryProportional hazards modelImmunologyCell BiologyHematologyAnagrelidemedicine.diseaseBiochemistrySettore MED/15 - Malattie Del Sanguemyelofibrosis survivalTransplantationLog-rank testPolycythemia veraInternational Prognostic Scoring SystemInternal medicinemedicinebusinessMyelofibrosisSurvival analysismedicine.drugBlood
researchProduct

Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System …

2020

Accurate prognostic tools are crucial to assess the risk/benefit ratio of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with myelofibrosis (MF). We aimed to evaluate the performance of the Myelofibrosis Transplant Scoring System (MTSS) and identify risk factors for survival in a multicenter series of 197 patients with MF undergoing allo-HCT. After a median follow-up of 3.1 years, 47% of patients had died, and the estimated 5 year survival rate was 51%. Projected 5-year risk of nonrelapse mortality and relapse incidence was 30% and 20%, respectively. Factors independently associated with increased mortality were a hematopoietic cell transplantation-specific comorbidity…

Oncologymedicine.medical_specialtyTransplantation ConditioningScoring systemCyclophosphamideSurvivalMyelofibrosisPrognostication03 medical and health sciences0302 clinical medicineMyelofibrosis Prognostication Risk factors Survival TransplantationInternal medicineHumansTransplantation HomologousMedicineMyelofibrosisSurvival rateTransplantationFramingham Risk Scorebusiness.industryIncidence (epidemiology)Hematopoietic Stem Cell TransplantationHematologyPrognosismedicine.diseaseTransplantationTreatment OutcomeRisk factorsPrimary Myelofibrosis030220 oncology & carcinogenesisCord bloodbusiness030215 immunologymedicine.drug
researchProduct

Mandibular ramus flexure and gonial eversion as morphologic indicators of sex.

2002

Summary Recently, two mandibular traits – ramus flexure and gonial eversion – have come under close scrutiny (Loth & Henneberg 1996, 2000). The present study investigates the reliability of these two traits when each is applied as a single and independent indicator of sex, including the question of repeatability. The investigation was designed to give insights into possible confounding factors such as age and remodeling after tooth loss. Two samples, one of forensic (N = 153) and one of archaeological provenance (N = 80), were examined. The forensic sample was evaluated by a single observer while the archaeological sample was independently scored by three different observers. The results do…

OrthodonticsAdultMaleSex Determination AnalysisScoring systemConfoundingReproducibility of ResultsAnatomyMandibleBiologyMiddle AgedSex FactorsAnthropologyTooth lossmedicineForensic AnthropologyHumansFemalemedicine.symptomMandibular ramusHomo : internationale Zeitschrift fur die vergleichende Forschung am Menschen
researchProduct

A preliminary analysis in the preparation and obturation of oval canals

2011

Objective: 1) to observe the appearance of uninstrumented recesses in oval canals after instrumentation using circumferential filing. 2) To determine the quality of obturation both with cold lateral compaction and thermo plasticized gutta-percha technique in these recesses Study design: Twenty non-carious, freshly extracted human mandibular incisors with single canals were divided into group I (n=10) and group II (n=10) according to the two different obturation methods. The sectioned roots were prepared with flexofiles (Dentsply, Maillefer) ranging from #15 to #40 by using circumferential filing. The obturated specimens were horizontally sectioned at 5 mm from the apex. Each section was obs…

OrthodonticsObturation techniqueScoring systemMaterials scienceGroup iiMagnificationMineralogyOdontología:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludPreliminary analysisStereo microscopeUNESCO::CIENCIAS MÉDICASStatistical analysissense organsGeneral Dentistry
researchProduct

SOX2 and BCL-2 Expressions in Odontogenic Keratocyst and Ameloblastoma

2020

Background The purpose of this experimental study was to compare the immunohistochemical expression of SOX2 and BCL-2 in Odontogenic Keratocyst (OKC) and Ameloblastoma (AB) specimens, and to identify a possible correlation in their expression. Material and Methods Immunohistochemical analysis was performed to evaluate SOX2 and BCL-2 expression in OKC (n = 20) and AB (n = 20). The immunoexpression was analyzed by a quantitative and qualitative scoring system. The comparison between the immunoexpression of SOX 2 and BCL-2 was assessed by the Mann-Whitney U-test. Spearman’s correlation coefficient evaluated the correlation between SOX2 and BCL-2 expressions. Results SOX2 and BCL-2 expression w…

Pathologymedicine.medical_specialtyScoring systemOdontogenic TumorsBiologyAmeloblastoma03 medical and health sciences0302 clinical medicineSOX2stomatognathic systemmedicineHumansKeratocystAmeloblastomaGeneral DentistryOral Medicine and PathologyResearchSOXB1 Transcription Factors030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]OdontogenicOtorhinolaryngologyProto-Oncogene Proteins c-bcl-2UNESCO::CIENCIAS MÉDICASembryonic structuresOdontogenic CystsImmunohistochemistrySurgeryFull thicknessmedicine.symptomImmunostainingMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

2019

Primary myelofibrosis (PMF) is a myeloproliferative neoplasm in which clonal proliferation of hematopoietic stem cells and bone marrow fibrosis coexist.1 Patients may eventually die due to leukemic progression, which occurs in up to 20% of cases, or because of cardiovascular comorbidities or cytopenia, which causes susceptibility to infections and bleeding.2 Myelofibrosis diagnosis relies upon the evaluation of several clinical and laboratory criteria suggested by the World Health Organization (WHO) in 2016.3 The major mutations leading to myelofibrosis usually occur in the JAK2, CALR, and MPL genes. However, in almost 10% of the cases, none of the above-mentioned mutations can be detected …

PharmacologyCytopeniamedicine.medical_specialtyRuxolitinibbusiness.industryIPSSruxolitinibprimary myelofibrosilcsh:RM1-950Case ReportGeneral Medicinemedicine.diseaseDiscontinuationPolycythemia veralcsh:Therapeutics. PharmacologyInternational Prognostic Scoring SystemInternal medicinemedicineprimary myelofibrosisMolecular MedicineMyelofibrosisAdverse effectbusinessMyeloproliferative neoplasmmedicine.drugDrugs in Context
researchProduct

Reyn kuvio (Rey-Osterrieth Complex Figure, ROCF) toiminnanohjauksen mittarina

2008

Rey-Osterrieth Complex FigureROCFBoston Qualitative Scoring SystemBQSStoiminnanohjaus
researchProduct